Journal Guide

Submit your paper to Microcirculation - visit the ScholarOne manuscript submission site Microcirculation features original contributions that are the result of investigations contributing significant new information relating to the vascular and lymphatic microcirculation addressed at the intact animal, organ, cellular, or molecular level. Papers describe applications of the methods of physiology, biophysics, bioengineering, genetics, cell biology, biochemistry, and molecular biology to problems in microcirculation. The journal also publishes state-of-the-art reviews that address frontier areas or new advances in technology in the fields of microcirculatory disease and function. Specific areas of interest include: Angiogenesis, growth and remodeling; Transport and exchange of gasses and solutes; Rheology and biorheology; Endothelial cell biology and metabolism; Interactions between endothelium, smooth muscle, parenchymal cells, leukocytes and platelets; Regulation of vasomotor tone; and Microvascular structures, imaging and morphometry. Papers also describe innovations in experimental techniques and instrumentation for studying all aspects of microcirculatory structure and function.

Oncology Research and Treatment offers an interdisciplinary forum for cancer research and treatment. Peer-reviewed original and review articles cover a wide range of aspects in medical hematology and oncology, surgical, gynecological, pediatric, and urological oncology, dermatological oncology, diagnostics, radiation oncology, psychological care, pathology, clinical-translational oncology, and oncological rehabilitation. Oncology Research and Treatment is addressed to clinicians and practitioners working and researching in the field of hematology and oncology.
The focus of Oncology Research and Treatment is to report clinical and translational research. Basic research is not in the scope of the journal.

Pediatric Blood & Cancer will publish in print and online, the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood, including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.

Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Of interest are clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from all over the world are considered for publication. The journal is not dependent on or connected with any organization or society. Read More: http://informahealthcare.com/page/pho/Description.

Platelets is an international, fully peer-reviewed journal covering all aspects of platelet-related research. The Journal publishes original articles, review articles and correspondence on blood platelets and platelet-related areas with a view to providing a focus for new information on all aspects of this important blood component.Platelets provides the opportunity for contributors and readers from all scientific several disciplines to engage with progress on platelet function, biochemistry, signal transduction, pharmacology and therapeutics, interaction with other cells in the blood vessel wall, and the contribution of platelets and platelet-derived products to health and disease.From September 2009, in addition to the usual reviews and research articles, there is a new Methods section. This will become a unique feature of Platelets. With the growing complexity and enormous range of different methodologies involved in research on platelets, coupled with increasing utility of new technologies, we envisage that this section will be of huge benefit to platelet researchers worldwide. This should not only improve standardization between laboratories but provide up-to-date and detailed descriptions of both old and new methods that are often difficult to replicate and may thus help to resolve controversies in the field.*© Thomson ISI Journal Citation Reports® 2012.

Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published. Papers are accepted on a worldwide basis.Editorial Office:Radiotherapy and Oncology Secretariat, Professor Jens Overgaard, M.D., Danish Cancer Society, Department of Experimental and Clinical Oncology, Aarhus University Hospital, Building 5, Norrebrogade 44, DK 8000 Aarhus C, DENMARK (Tel: +45 89 49 26 29; Fax: +45 86 19 71 09; email: ro@oncology.dk).

A major multidisciplinary journal on vascular diseasesStraddling the crossroads where many disciplines meet, STV takes a new look at vascular and thrombotic diseases and provides every reader with an essential supplement to his or her speciality.STV, which brings together the most up-to-date concepts in biology and clinical subjects, plays a special role in training and informing practitioners in all the relevant fields.The online version of Sang Thrombose Vaisseaux is available. All articles published since 1997 can now be accessed online. Recent articles are available by pay per view or by subscription while older ones have free access.

Seminars in Hematology is a topical journal that focuses on subjects of current importance in clinical hematology and related fields. The journal is devoted to making the present status of such topics and the results of new investigations readily available to the practicing physician. Seminars in Hematology is of special interest to hematologists, oncologists, internal medicine specialists, blood bankers and specialists in thrombosis and hemostasis.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com

Seminars in Oncology brings you current, authoritative, and practical reviews of developments in the diagnosis and management of patients with cancer. Each issue examines a single topic of clinical importance. You're guided through each cancer's biology, epidemiology, and pathophysiology, its clinical presentation and therapeutic options, and appropriate follow-up measures. This journal makes an excellent addition to every oncology practice.2013 Topics: Volume 40The Evolving Landscape of Neuroendocrine TumorsEmily K. BergslandCardio-oncology: The Relationships Between the Heart and CancerMarc L. SchwartzProstate CancerLeonard Gomella, Adam Dicker, and William Kevin KellyRenal CancerBrian I. Rini and Thomas PowlesMultiple MyelomaAndrzej J. JakubowiakLung CancerDavid CarboneBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com

Seminars in Thrombosis and Hemostasis is a topic driven review journal that focuses on all issues relating to hemostatic and thrombotic disorders. As one of the premiere review journals in the field, Seminars in Thrombosis and Hemostasis serves as a comprehensive forum for important advances in clinical and laboratory diagnosis and therapeutic interventions.Seminars offers an informed perspective on today's pivotal issues, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques. The journal also frequently publishes sponsored supplements to further highlight emerging trends in the field.Hormones, Endocrine Disorders and HemostasisHemostatic Factors in the Etiology, Early Detection, Prevention and Management of Pre-eclampsia.

SHOCK; is the only journal exclusively devoted to the etiology, cellular and molecular mechanisms, and therapeutic approaches to the treatment of shock in a comprehensive and coherent manner, while still maintaining a clear focus on the pathobiology of shock. The journal includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. SHOCK; is dedicated to meeting the present and future information needs of investigators involved in sophisticated basic and clinical studies of shock, trauma, sepsis, endotoxemia, ischemia/reperfusion, inflammation, and other related pathophysiologic states.For more information, visit www.shockjournal.org.

STEM CELLS, a peer-reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology.

STEM CELLS welcomes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects of characterization and manipulation from the bench to patient care. The journal covers all aspects of stem cell research including embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: epigenetics, genomics, proteomics, and metabonomics; cancer stem cells; translational and clinical research; and regenerative medicine.

Stem Cells and Development focuses on stem cells of all tissue types and their potential therapeutic applications. The Journal continues its tradition of providing a forum for animated discussion of contentious issues in conventional medicine.Stem Cells and Development covers: Controversial issues on stem cell research Stem cells of all tissues and organs Embryogenesis and adult counterparts of this process Physical processes linking stem cells, primary cell function, and structural development Transition from genes to physical effects: hypotheses and data Development of vasculature, CNS, and other germ layer development and defects Processes included in development: how the molecules work Pluripotentiality of adult stem cells The role of various mediators and how genetic factors affect development at a physical level Correspondence and concise, comprehensive reviews.

The Lancet Haematology launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence that advocate a change in, or illuminate, haematological clinical practice.

The Lancet Haematology builds onThe Lancet journals' reputation for publishing high-impact research and covers the breadth of clinical haematology which includes, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.

Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.

Visit http://www.thelancet.com/haematology for more information.